Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Stockmann’s Capital Markets Day 2023

Stockmann plc, Press release 25.9.2023   Invitation to Stockmann’s Capital Markets Day 2023   Stockmann Group invites investors, analysts and media representatives to its Capital Markets Day (CMD). The event will be held on Thursday, 16 November 2023 at 13:00−16:30 EET.   The CMD will be held as a hybrid event. Institutional investors, analysts and media representatives are welcome to attend the event, which will take place at Allas Sea Pool at Katajanokanlaituri 2 A in Helsinki, Finland. A live webcast of the event can be followed by this link:  https://stockmann.

Invitation to Skanska’s Capital Markets Day

We are pleased to invite investors, analysts and financial media to our Capital Markets Day on November 21, 2023 in London.Venue: 30 St Mary Axe (The Gherkin), London Registration and lunch: 12:15 GMT Presentations: 13:00 – 17:00 GMT, followed by mingle and light dinner Session 1: Group and business streams (also live webcast) Session 2: Business insights: Skanska UK, US Civil, Commercial Property Development (live audience only) Site visit (optional): HS2 Euston station, 10:00 – 12:15 GMT   A warm welcome! The Group Leadership Team and Investor Relations, Skanska AB

Biosergen and Alkem Laboratories Ltd collaborates to develop anti-infective for severe fungal infections

Stockholm, September 25, 2023: Biosergen AB (Biosergen) and Alkem Laboratories Ltd. (Alkem) are pleased to announce the signing of a co-development and license agreement for BSG005, an innovative polyene macrolide, through phase II and phase III trials for sale in the Indian market.Biosergen is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases. After the successful completion of two phase I studies, the first patient trial will be conducted in India on patients with severe fungus disease, who are intolerant or resistant to treatment with

Inside information: Stockmann commences a strategic assessment; considers changing the Group’s name to Lindex Group and investigates strategic alternatives for the Department Stores business

STOCKMANN plc, Inside Information 25.9.2023 at 8:30 EEST   Inside information: Stockmann commences a strategic assessment; considers changing the Group’s name to Lindex Group and investigates strategic alternatives for the Department Stores business   Stockmann plc’s Board of Directors has today decided to initiate a strategic assessment to crystallise shareholder value by refocusing the Group's business on Lindex. As part of the strategic assessment, Stockmann plc is considering a name change to Lindex Group and will investigate strategic alternatives for the Stockmann

Scandi Standard appoints Fredrik Sylwan as new Group CFO

PRESS RELEASE, 25 September 2023 Scandi Standard, the leading poultry producer in the Nordic region and Ireland, is pleased to announce the appointment of Fredrik Sylwan as new CFO effective 15 January 2024. Sylwan brings extensive experience and a demonstrated skill set in finance and strategic leadership, which will be instrumental to Scandi Standards profitable growth journey.   Fredrik Sylwan has over 20 years of finance and executive leadership experience, and was recently CFO of Perrigo Nordic/ACO Hud Nordic, Vice President Finance and Strategy at Swedish Match and Management

“LEQEMBI[®] Intravenous Infusion” approved for the treatment of Alzheimer’s disease in Japan

Stockholm, September 25, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that “LEQEMBI[®] Intravenous Infusion” (200 mg, 500mg, lecanemab) has been approved in Japan as a treatment for slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD). The regulatory approval in Japan announced today, entitles BioArctic to a milestone of EUR 17 M.LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril[1]) and insoluble forms of Aβ. LEQEMBI is the

Circio: circRNA poster to be presented at the 15th international adenovirus meeting

Oslo, Norway, 25 September 2023 – Circio Holding ASA (OSE: CRNA) today announces that an abstract describing its circular RNA platform has been accepted for poster presentation at the 15th international adenovirus meeting in Brac Island, Crotia. The abstract describes the development of Circio’s proprietary circAde vector system for therapeutic protein expression. The abstract describes the development of Circio’s proprietary circVec vector system for therapeutic protein expression. Key elements necessary for circRNA biogenesis were systematically screened and optimized to facilitate

SBB strengthens liquidity with approximately SEK 8 billion and presents decentralised group structure

Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB" or the "Company") divests 1.16 per cent of SBB EduCo AB ("EduCo") to Brookfield Super-Core Infrastructure Partners ("Brookfield") for approximately SEK 242 million and becomes a minority-owner. EduCo will repay part of its inter-company loan from SBB, resulting in SBB receiving approximately SEK 7.8 billion in cash. SBB today also decided on a decentralised group structure that enhances transparency and funding options. “I am very pleased to present a significant liquidity injection and a continued strong collaboration with Brookfield.

Canine Lives Cut Short: Startling Research Reveals 'Unwanted Behaviours' as Top Cause of Death among Dogs Under Three

It’s an easy assumption that well-behaved dogs are the ones that sit when asked, and the ‘naughty’ ones bark outside the window. However, there’s a very serious side to the way in which dogs behave, with research revealing that ‘unwanted behaviours’ are the leading cause of death in dogs under three-years-old in the UK1.[A dog lying on the floor Description automatically generated] This shocking statistic includes both dogs that have been euthanised as a direct result of undesirable actions as well as those who have experienced a heartbreaking end because of accidents attributed to ‘

BPC receives an order from a leading global sugar producer for biogas production

BPC Instruments AB (“BPC” or the “Company”) has received a purchase order from a leading multinational manufacturer of sugar, alcohol, and starch, headquartered in Belgium. The order encompasses the delivery of two complete AMPTS[®] III systems, with a total order value exceeding 54,000 euros. The revenue generated from the order is expected to be included in the third quarter of this year.CEO Dr. Jing Liu comments: “Throughout this year, BPC has experienced a remarkable period of growth, characterized by strong financial results and a consistently robust sales pipeline, including a

Nordea Bank Abp: Repurchase of own shares on 22.09.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares22.09.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 22.09.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |42,611 |10.35 |440,836.36

Publication of a Prospectus

Regulatory Announcement Royal Bank of CanadaSeptember 22, 2023Publication of ProspectusNot for release, publication or distribution, directly or indirectly, in or into the United States.Royal Bank of Canada has today sent a notice to Noteholders relating to the issue of the GBP750,000,000 Floating Rate Senior Notes due September 2023, Series 66646 (ISIN: XS2536797512) issued on September 23, 2022 (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme").Noteholders have been informed that pursuant to Condition 14 (fourth paragraph, item (ii) of

Moody’s changes Intrum’s credit rating

Moody’s Investors Service (“Moody’s”) has today announced its downgrading of Intrum AB’s credit rating (corporate family rating) from Ba3 to B1, with a stable outlook.De-leveraging and de-risking of the balance sheet is Intrum’s key priority as highlighted during the recent Capital Markets Day. Intrum’s discretionary cash generation remains strong with any upcoming debt maturities until the end of 2025 fully covered by organic cash flow generation as well proceeds from market exits and portfolio sales currently being executed. “We have a well-balanced and highly diversified business,

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BK1PKQ95 Issuer Name Fidelity European Trust PLC UK or Non-UK Issuer UK 2. Reason for Notification Other Comments The increase in shareholding outlined in this form has been driven by the all-share combination of Rathbones Group Plc with Investec Wealth & Investment Limited which completed on 21st September 2023. 3. Details of person subject to the notification obligation Name Rathbones Investment Management Ltd City of registered office (if applicable) London

Katalysen Ventures extends warrant subscription period

Katalysen Ventures AB (publ) ("Katalysen Ventures") announces an extension of the subscription period for its ongoing warrant issue.Katalysen Ventures announces an extension of the subscription period for its ongoing warrant issue, with the subscription period being extended until the 30th of September. This extension aims to ensure ample time to successfully close ongoing discussions with the interested and relevant parties involved.

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 22 September 2023 the Company bought 93,523 of its own shares for cancellation at a price of 212.360 pence per share.  The Company's issued ordinary share capital is 563,403,839 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 477,774,291. The above figure (477,774,291) may be used by shareholders as the denominator for the

#23-303 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#23-302 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Bittium Corporation: SHARE REPURCHASE 22.9.2023

Bittium Corporation  ANNOUNCEMENT  22.9.2023 Bittium Corporation: SHARE REPURCHASE 22.9.2023 In the Helsinki Stock Exchange Trade date           22.9.2023Bourse trade         BuyShare                  BITTIAmount             2 800 SharesAverage price/ share    3,7750 EURTotal cost            10 570,00 EUR Bittium Corporation now holds a total of 198 307 sharesincluding the shares repurchased on 22.9.2023 On behalf of Bittium Corporation Nordea Bank Oyj

DNB Bank ASA – status of share buy-back programme after week 38 2023

On 17 July 2023, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.5 percent of the company’s own shares, which represents a total of 23,139,197 shares. The total transaction value will not exceed NOK 4.9 billion. Up to 15,271,870 shares will be bought back on trading venues by 18 October 2023, and a proposal will be made at the Annual General Meeting in 2024 to cancel the shares. At the same meeting it will also be proposed to redeem the remaining shares – up to 7,867,327 shares – from the Norwegian Government,

Board Changes

Faron Pharmaceuticals Ltd. (“Faron” or the “Company”)     Board Changes     Company announcement, September 22, 2023   TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, is pleased to announce the appointment of Ms. Christine Roth and Dr. Marie-Louise Fjällskog as Non-Executive Directors of the Company with immediate effect following the passing of all resolutions put to shareholders of the Company at the Extraordinary General

There are no items matching the current filter
There are no more items matching the current filter
Back to top